Ukwelashwa komdlavuza wamaphaphu weseli ongeyona omncane
Ukwelashwa komdlavuza wamaphaphu ikakhulukazi kusetshenziswa ukuhlinzwa, iradiotherapy kanye nokwelashwa ngamakhemikhali, futhi ukuhlinzwa kuseyindlela ephumelela kakhulu yokwelapha umdlavuza wamaphaphu ezigabeni zokuqala nezimaphakathi. Kodwa-ke, kumdlavuza wamaphaphu omaphakathi, ngenxa yendawo ekhethekile yesilonda, izinqubo zokuhlinza zendabuko zinzima ukuzisebenzisa, futhi iziguli zivame ukulahlekelwa ithuba lokwelashwa.
Central lung cancer refers to lung cancer that occurs in the bronchi, lobular bronchus, and lung bronchus, with squamous carcinoma and undifferentiated carcinoma mostly. Surgery is rarely used for central umdlavuza wamaphaphu. This is because central lung cancer is located near the hilum. It is difficult to remove, and the surgical effect is not ideal. It is easy to induce bone metastasis . Therefore, in the past, clinicians often were helpless when treating central lung cancer.
Ngisho nokuthuthukiswa kobuchwepheshe bokuhlinza amaphaphu, ukusetshenziswa kwe-intrapericardial pneumonectomy kuye kwandisa izinkomba zokuhlinzwa ngezinga elithile futhi kwenyusa izinga lokuhlehla. Kodwa-ke, ngokusho kwedatha yomtholampilo, ekwelapheni umdlavuza wamaphaphu ophakathi, ukusebenza kahle kokuhlinzwa kokuhlinzwa akuhlolisiswa kahle, ikakhulukazi ezigulini ezinomdlavuza wamaphaphu othuthukile, ukuhlinzwa kabusha ngokuvamile akukhuthazwa. Ukwelashwa komdlavuza wamaphaphu omaphakathi, noma ngabe kuyi-thoracotomy, ukuhlinzwa kokuhlola kanye nokuhlinzwa kwe-palliative. Iziguli ezindala zinenhliziyo embi futhi kunzima ukudlulisa i-anesthesia yokuhlinzwa.
The birth of EDGE has completely changed the dilemma of the treatment of central lung cancer. This technology can effectively remove isisu lesions in vitro and remove the central lung cancer lesions in vitro. The treatment effect can be comparable to surgical operations, but there is no surgical operation for patients. Caused by trauma and side effects.
Experts from the Global Oncologist Network introduced that EDGE, which was launched in 2014, is by far the most advanced in-vitro non-invasive tumor removal technology. It can remove tumor lesions in the body without any damage to the patient’s body and immune system. This technique is particularly suitable for patients with tumors that were previously inoperable, such as lung cancer, brain tumors, spine tumors, ikhanda nentamo tumors, pancreatic cancer, prostate cancer and other diseases.
Male, 53 years old, suffering from umdlavuza wamaphaphu weselula ongewona omncane with multiple metastatic brain tumors. In early June 2014, he went to Henry Ford Hospital for EDGE non-invasive radiosurgery. EDGE treatment 3 times, continuous daily treatment, once a day, each time takes about 12 minutes. The first time after operation, the patient’s headache was obviously relieved, and the patient is generally in good condition so far. During the follow-up in early September, the local hospital in Taipei underwent MRI examination: 0.9 and 4 cm3 izimila ebuchosheni almost disappeared, and 6.5 cm3 tumors in the lungs decreased by more than 98%.
I-EDGE Radiosurgery system (EDGE radiosurgery tumor treatment system) yathuthukiswa yinkampani yase-American Varian futhi yagunyazwa yi-US FDA ngo-January 23, 2013. I-EDGE iwubuchwepheshe obusebenza kahle kakhulu bokususa isimila esingahlaseli. Isebenzisa i-FDA's Calypso® GPS eyingqayizivele yohlelo lwe-Body® kanye nesistimu yokuqapha i-surface beam egunyazwe ngomhla ka-Julayi 21, 2014 ukuze ihlole ngamandla futhi ikhiye ngesikhathi sangempela ngemvamisa ephezulu efika kuma-millisecond angu-10. Ngesikhathi sokwelashwa, isimila "siyabaleka", kuhlanganiswe nesizukulwane esisha se-IGRT nobunye ubuchwepheshe bokuqondisa izithombe, futhi sisebenzisa i-collimator enamandla kakhulu ye-HD-MLC efinyelela ku-2400MU / min ukuze kususwe izicubu zesimila cishe kungabikho ukunemba kwensalela.
Uhlelo lokuqala lomhlaba lwe-EDGE lwazinza e-United States Henry Ford Health System (HFHS, American Henry Ford Medical Group) ngoSepthemba 2013, futhi lwaqala ukusebenza okokuqala ngoMashi 2014.
EDGE has an excellent therapeutic effect on solid tumors such as head tumors, lung cancer including breast cancer, spine tumors, umdlavuza wesibindi and other tumors that are difficult to perform in conventional surgery. The entire treatment process is non-invasive, no anesthesia, no hospitalization, each treatment time is 8-20 minutes, once a day, up to 5 times, continuous daily treatment. EDGE treatment has almost no side effects, almost no damage to important organs, and almost no effect on the body’s anti-cancer immune system.
Izinzuzo ze-EDGE radiosurgery non-invasive surgery
Ø Isikhathi esifushane sokwelashwa: imizuzu engu-8-20 isikhathi ngasinye;
Ø Izikhathi zokwelashwa: ingqikithi yezikhathi ezingu-1-5, ukwelashwa okuqhubekayo, kanye ngosuku;
Ø Ukusebenza kahle okuphezulu: i-tumor foci eminingi ingasuswa ngesikhathi esifanayo;
Ø Ukulandelelwa kwesikhathi sangempela kokuphunyuka nokususwa kwesimila: Landela futhi ukhiye isimila “sokuphunyuka” ngemvamisa ephezulu kakhulu yama-millisecond angu-10 bese uyasikhipha;
Ø Umphumela omuhle wokukhipha: amandla aphezulu, ukunemba okuphezulu nokunemba okuphezulu, ukususwa okuphelele kwezicubu zesimila cishe kungabikho izinsalela;
Ø Cishe akukho monakalo ezithweni ezibalulekile: cishe akukho monakalo ezicubu nezitho ezibalulekile;
Ø Ukulimala kwezivikeli mzimba ezilwa nomdlavuza kunomphumela omncane: cishe akunawo umthelela kumasosha omzimba esiguli;
Ø Ukufaneleka: akukho izinzwa futhi akukho esibhedlela;
Ø Imiphumela engemihle: Cishe ayikho imiphumela emibi.
